BrightFocus is proudly supporting 182 cutting-edge research grants, fueling the global fight against Alzheimer’s disease, macular degeneration, and glaucoma.
BrightFocus Foundation’s 2026 research portfolios highlight the groundbreaking science the Foundation is supporting to accelerate cures for Alzheimer’s disease, macular degeneration, and glaucoma. Spanning 17 countries, these research projects are investigating bold, “what-if” ideas that hold the greatest promise to change the trajectory of these diseases.
Made possible through the generosity of our donors, these projects are carefully vetted by world-renowned scientists who serve on the Foundation’s Scientific Review Committees, ensuring the most innovative and promising ideas that will advance our understanding of these diseases of mind and sight. Learn more about how you can support this important work.
Alzheimer’s Disease Research is currently investing $33 million in 108 research projects across 14 countries.
View the Alzheimer’s Disease Research Portfolio in magazine format or view a printable format (PDF).
Macular Degeneration Research is currently investing $14 million in 42 research projects across eight countries.
View the Macular Degeneration Research Portfolio in magazine format or view a printable format (PDF).
National Glaucoma Research is currently investing $5 million in 32 research projects across four countries.
View the National Glaucoma Research Portfolio in magazine format or view a printable format (PDF).
BrightFocus Foundation is a premier global nonprofit funder of research to defeat Alzheimer’s, macular degeneration, and glaucoma. Since its inception more than 50 years ago, BrightFocus and its flagship research programs—Alzheimer’s Disease Research, Macular Degeneration Research, and National Glaucoma Research—has awarded more than $330 million in research grants to scientists around the world, catalyzing thousands of scientific breakthroughs, life-enhancing treatments, and diagnostic tools. We also share the latest research findings, expert information, and resources to empower the millions impacted by these devastating diseases. Learn more at brightfocus.org.
Disclaimer: The information provided here is a public service of BrightFocus Foundation and is not intended to constitute medical advice. Please consult your physician for personalized medical, dietary, and/or exercise advice. Any medications or supplements should only be taken under medical supervision. BrightFocus Foundation does not endorse any medical products or therapies.
Scientists funded by BrightFocus received an average of 8x more follow-on funding, leading to the development of new treatments, risk reduction strategies, and diagnostic tools.
BrightFocus Foundation’s 2026 annual report highlights cutting-edge research and public awareness across Alzheimer's disease, macular degeneration, and glaucoma.
A new campaign launched during World Alzheimer’s Month features renowned actor, producer, and writer Andre Royo, who lost his mother, Andrea Royo, to Alzheimer’s disease in 2024.
BrightFocus Foundation today announced that Stacy Pagos Haller has shared her intention to retire as president and chief executive officer following the successful completion of a national search and the appointment of a successor, after 16 years of leadership.
A pioneering clinician-scientist at Memorial Sloan Kettering Cancer Center, Dr. Abramson has transformed understanding and treatment of eye cancers worldwide.
At a ceremony recognizing 2026 vision grant recipients, these prestigious awards honor five standout scientists whose work is shaping the future of prevention, treatments, and cures for macular degeneration and glaucoma—two leading causes of vision loss.
Donate Now to Fund Critical Research
Your gift today can help drive innovation in Alzheimer's, macular degeneration, and glaucoma research. By donating, you’ll support life-changing research and provide valuable resources for those affected by these devastating diseases. Give now to fuel hope and bring us closer to finding cures.
